Physician Prescribing Information Solu-Medrol Injection Novaplus U
To administer by intravenous (or intramuscular) injection, prepare solution as directed
40 mg Act-O-Vial System (Single-Use Vial) 125 mg Act-O-Vial System (Single-Use Vial Solu-MEDROL is a steroid that prevents the release of substances in the body that cause inflammation
The product's dosage form is injection, powder, for solution and is administered via intramuscular; intravenous SOLU-MEDROL (methylprednisolone sodium succinate) Product Monograph Page 7 of 39 As adjunctive therapy in life threatening conditions (e
Cantu RC, MD Harvard Neurological Service, Boston, Massachusetts
The chemical name for methylprednisolone is pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-6-methyl-, (6α,11β)-and the molecular weight is 374
The product's dosage form is injection, powder, for solution and is administered via intramuscular; intravenous The following 23 images provide visual information about the product associated with Solu-medrol NDC 0009-0018 by Pharmacia & Upjohn Company Llc, such as packaging, labeling, and the appearance of the drug itself
In order to minimize the incidence of dermal and subdermal atrophy, care must be exercised not to exceed recommended doses in injections
Pharmacia & Upjohn Company LLC: 618054084: ANALYSIS(0009-0003, 0009-0018, 0009 SOLU-MEDROL- methylprednisolone sodium succinate injection, powder, for solution Pharmacia & Upjohn Company LLC----- Injection of SOLU-MEDROL may result in dermal and/or subdermal changes forming depressions in the skin at the injection site
In order to minimize the incidence of dermal and subdermal atrophy, care must be exercised not to exceed recommended dosages in injections
The product's dosage form is injection, powder, for solution and is administered via intramuscular; intravenous form
Distributed by Pharmacia & Upjohn Co
Pharmacia & Upjohn Company LLC: 618054084: ANALYSIS(0009-0003, 0009-0018, 0009 The Office of Bioequivalence has determined your Methylprednisolone Sodium Succinate for Injection USP, 40 mg (base)/vial and 125 mg (base)/vial to be bioequivalent and, therefore, therapeutically equivalent to the reference listed drug (RLD), Solu-Medrol, 40 mg (base)/vial and 125 mg (base)/vial, of Pharmacia & Upjohn Co
The NDC Packaged Code 0009-0047-22 is assigned to a package of 25 vial in 1 carton / 2 ml in 1 vial (0009-0047-25) of Solu-medrol, a human prescription drug labeled by Pharmacia & Upjohn Company Llc
Pharmacia & Upjohn Company LLC: 618054084: API MANUFACTURE(0009 Injection of SOLU-MEDROL may result in dermal and/or subdermal changes forming depressions in the skin at the injection site
In order to minimize the incidence of dermal and subdermal atrophy, care must be exercised not to exceed recommended doses in injections
The product's dosage form is injection, powder, for solution and is administered via intramuscular; intravenous form
Methylprednisolone sodium succinate, USP, is the sodium succinate ester of methylprednisolone, and it occurs as a white, or nearly white, odorless hygroscopic, amorphous solid
Details of the Supplier of the Safety Data Sheet Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-800-879-3477
DEPO-MEDROL is an anti-inflammatory glucocorticoid for intramuscular, intra-articular, soft tissue or intralesional injection
The product's dosage form is injection, powder, for solution, and is administered via intramuscular; intravenous form
SOLU-MEDROL is available in several strengths and packages for intravenous or intramuscular administration
first aid:get medical attention if symptoms persist
The NDC Packaged Code 0009-0047-26 is assigned to a package of 25 vial in 1 carton / 2 ml in 1 vial (0009-0047-27) of Solu-medrol, a human prescription drug labeled by Pharmacia & Upjohn Company Llc
PrSOLU-MEDROL® Methylprednisolone Sodium Succinate for Injection USP Sterile Powder 500 mg, 1 g Vials TM Pharmacia & Upjohn Company LLC Pfizer Canada Inc
New York, NY 10001
52
Methylprednisolone sodium succinate has the same Pfizer develops Safety Data Sheets (SDSs) for our products for the benefit of our customers who are employers
The product's dosage form is and is administered via form
SOLU-MEDROL may be administered by intravenous or intramuscular injection or by intravenous infusion, the preferred method for initial emergency use being intravenous
SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) The formulations containing benzyl alcohol should not be used in neonates
Solu-MEDROL is used to treat many different
SOLU-MEDROL (methylprednisolone sodium succinate) Product Monograph Page 9 of 39 4
About
MEDROL Tablets are indicated in the following conditions: 1
In order to minimize the incidence of dermal and subdermal atrophy, care must be exercised not to exceed recommended dosages in injections
The NDC Packaged Code 0009-0047-04 is assigned to a package of 25 vial in 1 carton / 2 ml in 1 vial of Solu-medrol, a human prescription drug labeled by Pharmacia & Upjohn Company Llc
SOLU-CORTEF- hydrocortisone sodium succinate injection, powder, for solution Pharmacia and Upjohn Company----- SOLU placebo-controlled study with methylprednisolone hemisuccinate, an IV corticosteroid, showed an increase in early (at 2 weeks) and late (at 6 months) mortality in patients with cranial trauma who were
Solu-Medrone should be given as an intravenous infusion over at least 30 minutes
Pharmacia & Upjohn Company LLC: 618054084: ANALYSIS(0009-0003
The structural formula is represented below: Hydrocortisone sodium succinate is a white or nearly white, odorless, hygroscopic amorphous solid
Thus, if constantly high blood levels are required, injections should be made every 4 Injection of SOLU-CORTEF may result in dermal and/or subdermal changes forming depressions in the skin at the injection site
In order to minimize the incidence of dermal and subdermal atrophy, care must be exercised not to exceed recommended doses in injections
The NDC Packaged Code 0009-0039-28 is assigned to a package of 25 vial in 1 carton / 1 ml in 1 vial (0009-0039-30) of Solu-medrol, a human prescription drug labeled by Pharmacia & Upjohn Company Llc
The structural formula is represented below: Hydrocortisone sodium succinate is a white or nearly white, odorless, hygroscopic amorphous solid
Relevant Identified Uses of the Substance or Mixture and Uses Advised Against Intended Use: Pharmaceutical product used as anti-inflammatory
Pharmacia & Upjohn Company LLC: 618054084: ANALYSIS(0009
The product's dosage form is injection, powder, for solution and is administered via intramuscular; intravenous form